Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW
710.00
+1.00 (0.14%)
At close: Dec 5, 2025
Aprogen Medicines Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 219,068 | 219,892 | 234,315 | 399,707 | 335,573 | 374,121 | |
| Market Cap Growth | -29.45% | -6.16% | -41.38% | 19.11% | -10.30% | -10.38% | |
| Enterprise Value | 672,644 | 604,604 | 577,535 | 792,820 | 588,371 | 548,883 | |
| Last Close Price | 710.00 | 776.00 | 960.00 | 1716.00 | 5055.00 | 6135.00 | |
| PS Ratio | 1.74 | 1.47 | 1.56 | 5.10 | 12.76 | 2.94 | |
| PB Ratio | 0.45 | 0.50 | 0.56 | 0.87 | -416.12 | 0.54 | |
| P/TBV Ratio | 2.76 | 1.44 | 1.67 | 1.93 | - | 1.19 | |
| P/FCF Ratio | - | - | - | - | - | 18.75 | |
| P/OCF Ratio | - | - | - | - | - | 16.60 | |
| EV/Sales Ratio | 5.33 | 4.03 | 3.84 | 10.12 | 22.38 | 4.32 | |
| EV/EBITDA Ratio | - | - | - | - | - | 76.74 | |
| EV/EBIT Ratio | - | - | - | - | - | 192.99 | |
| EV/FCF Ratio | -19.72 | - | - | - | - | 27.50 | |
| Debt / Equity Ratio | 0.51 | 0.26 | 0.30 | 0.20 | -560.94 | 0.12 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 11.98 | |
| Debt / FCF Ratio | - | - | - | - | - | 4.29 | |
| Asset Turnover | 0.18 | 0.25 | 0.25 | 0.14 | 0.04 | 0.17 | |
| Inventory Turnover | 1.35 | 1.88 | 1.90 | 1.85 | 1.55 | 5.37 | |
| Quick Ratio | 0.62 | 0.57 | 0.53 | 0.85 | 0.07 | 3.11 | |
| Current Ratio | 0.99 | 1.19 | 1.15 | 2.35 | 0.24 | 5.11 | |
| Return on Equity (ROE) | -31.66% | -23.40% | -22.14% | -50.45% | -34.60% | -5.41% | |
| Return on Assets (ROA) | -8.84% | -9.37% | -9.94% | -13.57% | -9.13% | 0.24% | |
| Return on Capital (ROIC) | -9.79% | -10.30% | -10.86% | -14.58% | -9.76% | 0.26% | |
| Return on Capital Employed (ROCE) | -18.00% | -18.20% | -20.30% | -22.90% | -172.00% | 0.40% | |
| Earnings Yield | -23.25% | -26.41% | -23.74% | -24.68% | -27.99% | -12.43% | |
| FCF Yield | -15.57% | -26.22% | -35.71% | -33.30% | -35.50% | 5.33% | |
| Buyback Yield / Dilution | -16.63% | -9.40% | -16.69% | -16.73% | -206.64% | -24.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.